when will semaglutide be back in stock Makers of compounded Wegovy, Ozempic threatened by FDA move Semaglutide shortage ends as FDA

3 Month Supply Of Injections for transforming weight care at the source

Korean pharmaceutical and biotech companies are heading to the American Diabetes Association (ADA) 2026 Scientific Sessions with obesity and metabolic disease pipelines that reflect the industry's shift beyond simple weight loss toward muscle preservation, management of metabolic comorbidities and m

Supply natural products, OEM of high purity natural products from mg to kg.

Looking beyond SELECT, which focused on secondary prevention, the ultimate prize is still to be seized primary prevention, a huge potential opportunity

Discover the gut bacteria that naturally boost GLP-1